0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaginitis Screening Kit Market Research Report 2026
Published Date: 2026-01-08
|
Report Code: QYRE-Auto-13D20346
Home | Market Reports | Health| Reproductive Health
Global Vaginitis Screening Kit Market Research Report 2026
BUY CHAPTERS

Global Vaginitis Screening Kit Market Research Report 2026

Code: QYRE-Auto-13D20346
Report
2026-01-08
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaginitis Screening Kit Market Size

The global Vaginitis Screening Kit market was valued at US$ 201 million in 2025 and is anticipated to reach US$ 316 million by 2032, at a CAGR of 6.6% from 2026 to 2032.

Vaginitis Screening Kit Market

Vaginitis Screening Kit Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Vaginitis Screening Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A Vaginitis Screening Kit is an in-vitro diagnostic (IVD) product set designed to screen for vaginal infections and microbiome imbalance associated with common etiologies such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV). The kit typically targets both point-of-care and laboratory workflows. It starts from standardized specimen collection (swabs and collection tubes) and integrates reagents and consumables—buffers, colorimetric/fluorescent reagents, lateral-flow strips, or molecular testing components—to generate rapid, actionable signals. By combining methods such as pH/amine tests with pathogen-specific antigen/nucleic-acid detection or enzymatic markers, the kit helps translate non-specific symptoms into an etiology-oriented screening outcome. This supports more rational treatment selection (antibacterial vs. antifungal vs. antiprotozoal), improves management of recurrence, strengthens risk control in pregnancy, and enables scalable, protocol-driven testing in primary care settings. In 2025, global Vaginitis Screening Kit production reached approximately 201 million units and price is about 1 usd/unit.The average gross profit margin of this product is 65%.
Women’s health is shifting from symptom-driven treatment to etiology-oriented, longitudinal management. Vaginitis—high-incidence, high-recurrence, and frequent visits—amplifies the value of standardized screening tools. Primary care and maternal-child systems increasingly demand rapid, easy-to-use, and clinically interpretable solutions, driving kits to evolve from single markers toward combined readouts with etiologic guidance. Meanwhile, more structured clinical pathways—antimicrobial stewardship, recurrence stratification, and partner management—make “test-then-treat” easier to operationalize, expanding commercialization across hospital, check-up, chain clinics, and telehealth channels.
Vaginitis presents highly overlapping symptoms and frequent mixed infections; if a kit covers limited targets or lacks clear interpretation logic, it risks missed detection, misclassification, and inappropriate therapy—eroding clinician trust and repurchase. Variability in sampling, transport, storage, and quality control across institutions raises the bar for robustness and operational tolerance. Compliance, clinical validation, and real-world evidence take time, while price competition can push the market into commoditization. Without strong academic evidence and guideline alignment, channel expansion alone rarely creates durable differentiation.
Demand is becoming scenario-stratified: hospitals prioritize etiologic typing, mixed-infection recognition, and consistent follow-up; primary care and outpatient settings emphasize fast turnaround and simplified workflows; out-of-hospital services value privacy-friendly sampling, standardization, and digital reporting. Management is getting more refined for recurrence-prone populations, pregnancy screening, and procedure/ART-related screening, pushing products from one-off testing toward closed-loop “screen-retest-evaluate” pathways. Integration with EMR/LIS accelerates structured results and traceability, steering kits toward platform-ready and connectivity-enabled upgrades.
The upstream stack centers on “sampling/consumables + core biochemical/immune/molecular inputs + carriers/packaging.” Swabs, collection tubes, and reaction consumables influence specimen recovery and inhibitor control; antibodies/antigens, enzymes, primers/probes, and dyes/substrates determine specificity and stability and are the most performance- and cost-sensitive inputs; nitrocellulose membranes, pads, and plastic housings drive consistency and batch variability in lateral-flow formats. Cold-chain or moisture-control packaging, desiccant systems, and quality documentation determine scalable delivery control. Competitive strength often hinges on stable sourcing of critical inputs, tight batch-to-batch management, and end-to-end quality control.
This report delivers a comprehensive overview of the global Vaginitis Screening Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vaginitis Screening Kit. The Vaginitis Screening Kit market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Vaginitis Screening Kit market comprehensively. Regional market sizes by Type, by Application, by Disease Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Vaginitis Screening Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Vaginitis Screening Kit Market Report

Report Metric Details
Report Name Vaginitis Screening Kit Market
Accounted market size in 2025 US$ 201 million
Forecasted market size in 2032 US$ 316 million
CAGR 6.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Molecular PCR Assays
  • POC Antigen Tests
  • Lab Culture Kits
  • Multiplex Panels
Segment by Disease Type
  • Bacterial Vaginosis
  • Yeast Infections
  • Trichomonas
  • Other
Segment by Sample
  • Swab
  • Wet
  • Lysis
  • Other
by Application
  • Hospital
  • Laboratory
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, QuidelOrtho, Becton Dickinson, Bio-Rad Laboratories, Hologic, Wuhan Easy Diagnosis, Wondfo, KHB, Hotgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Disease Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Vaginitis Screening Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Vaginitis Screening Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Vaginitis Screening Kit Market growing?

Ans: The Vaginitis Screening Kit Market witnessing a CAGR of 6.6% during the forecast period 2026-2032.

What is the Vaginitis Screening Kit Market size in 2032?

Ans: The Vaginitis Screening Kit Market size in 2032 will be US$ 316 million.

Who are the main players in the Vaginitis Screening Kit Market report?

Ans: The main players in the Vaginitis Screening Kit Market are Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, QuidelOrtho, Becton Dickinson, Bio-Rad Laboratories, Hologic, Wuhan Easy Diagnosis, Wondfo, KHB, Hotgen

What are the Application segmentation covered in the Vaginitis Screening Kit Market report?

Ans: The Applications covered in the Vaginitis Screening Kit Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the Vaginitis Screening Kit Market report?

Ans: The Types covered in the Vaginitis Screening Kit Market report are Bacterial Vaginosis, Yeast Infections, Trichomonas, Other

1 Vaginitis Screening Kit Market Overview
1.1 Product Definition
1.2 Vaginitis Screening Kit by Type
1.2.1 Global Vaginitis Screening Kit Market Value by Type: 2025 vs 2032
1.2.2 Molecular PCR Assays
1.2.3 POC Antigen Tests
1.2.4 Lab Culture Kits
1.2.5 Multiplex Panels
1.3 Vaginitis Screening Kit by Disease Type
1.3.1 Global Vaginitis Screening Kit Market Value by Disease Type: 2025 vs 2032
1.3.2 Bacterial Vaginosis
1.3.3 Yeast Infections
1.3.4 Trichomonas
1.3.5 Other
1.4 Vaginitis Screening Kit by Sample
1.4.1 Global Vaginitis Screening Kit Market Value by Sample: 2025 vs 2032
1.4.2 Swab
1.4.3 Wet
1.4.4 Lysis
1.4.5 Other
1.5 Vaginitis Screening Kit by Application
1.5.1 Global Vaginitis Screening Kit Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Laboratory
1.5.4 Others
1.6 Global Vaginitis Screening Kit Market Size Estimates and Forecasts
1.6.1 Global Vaginitis Screening Kit Revenue 2021–2032
1.6.2 Global Vaginitis Screening Kit Sales 2021–2032
1.6.3 Global Vaginitis Screening Kit Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Vaginitis Screening Kit Market Competition by Manufacturers
2.1 Global Vaginitis Screening Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global Vaginitis Screening Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Vaginitis Screening Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Vaginitis Screening Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Vaginitis Screening Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Vaginitis Screening Kit, Product Types and Applications
2.7 Global Key Manufacturers of Vaginitis Screening Kit, Date of Entry into the Industry
2.8 Global Vaginitis Screening Kit Market Competitive Situation and Trends
2.8.1 Global Vaginitis Screening Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Vaginitis Screening Kit Players Market Share by Revenue
2.8.3 Global Vaginitis Screening Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaginitis Screening Kit Market Scenario by Region
3.1 Global Vaginitis Screening Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Vaginitis Screening Kit Sales by Region: 2021–2032
3.2.1 Global Vaginitis Screening Kit Sales by Region: 2021–2026
3.2.2 Global Vaginitis Screening Kit Sales by Region: 2027–2032
3.3 Global Vaginitis Screening Kit Revenue by Region: 2021–2032
3.3.1 Global Vaginitis Screening Kit Revenue by Region: 2021–2026
3.3.2 Global Vaginitis Screening Kit Revenue by Region: 2027–2032
3.4 North America Vaginitis Screening Kit Market Facts & Figures by Country
3.4.1 North America Vaginitis Screening Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Vaginitis Screening Kit Sales by Country (2021–2032)
3.4.3 North America Vaginitis Screening Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaginitis Screening Kit Market Facts & Figures by Country
3.5.1 Europe Vaginitis Screening Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Vaginitis Screening Kit Sales by Country (2021–2032)
3.5.3 Europe Vaginitis Screening Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaginitis Screening Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Vaginitis Screening Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Vaginitis Screening Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific Vaginitis Screening Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaginitis Screening Kit Market Facts & Figures by Country
3.7.1 Latin America Vaginitis Screening Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Vaginitis Screening Kit Sales by Country (2021–2032)
3.7.3 Latin America Vaginitis Screening Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Vaginitis Screening Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaginitis Screening Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Vaginitis Screening Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa Vaginitis Screening Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaginitis Screening Kit Sales by Type (2021–2032)
4.1.1 Global Vaginitis Screening Kit Sales by Type (2021–2026)
4.1.2 Global Vaginitis Screening Kit Sales by Type (2027–2032)
4.1.3 Global Vaginitis Screening Kit Sales Market Share by Type (2021–2032)
4.2 Global Vaginitis Screening Kit Revenue by Type (2021–2032)
4.2.1 Global Vaginitis Screening Kit Revenue by Type (2021–2026)
4.2.2 Global Vaginitis Screening Kit Revenue by Type (2027–2032)
4.2.3 Global Vaginitis Screening Kit Revenue Market Share by Type (2021–2032)
4.3 Global Vaginitis Screening Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global Vaginitis Screening Kit Sales by Application (2021–2032)
5.1.1 Global Vaginitis Screening Kit Sales by Application (2021–2026)
5.1.2 Global Vaginitis Screening Kit Sales by Application (2027–2032)
5.1.3 Global Vaginitis Screening Kit Sales Market Share by Application (2021–2032)
5.2 Global Vaginitis Screening Kit Revenue by Application (2021–2032)
5.2.1 Global Vaginitis Screening Kit Revenue by Application (2021–2026)
5.2.2 Global Vaginitis Screening Kit Revenue by Application (2027–2032)
5.2.3 Global Vaginitis Screening Kit Revenue Market Share by Application (2021–2032)
5.3 Global Vaginitis Screening Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Vaginitis Screening Kit Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Vaginitis Screening Kit Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Company Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Danaher Vaginitis Screening Kit Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 Siemens Healthineers
6.4.1 Siemens Healthineers Company Information
6.4.2 Siemens Healthineers Description and Business Overview
6.4.3 Siemens Healthineers Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Siemens Healthineers Vaginitis Screening Kit Product Portfolio
6.4.5 Siemens Healthineers Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Thermo Fisher Scientific Vaginitis Screening Kit Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Sysmex
6.6.1 Sysmex Company Information
6.6.2 Sysmex Description and Business Overview
6.6.3 Sysmex Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sysmex Vaginitis Screening Kit Product Portfolio
6.6.5 Sysmex Recent Developments/Updates
6.7 BioMerieux
6.7.1 BioMerieux Company Information
6.7.2 BioMerieux Description and Business Overview
6.7.3 BioMerieux Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 BioMerieux Vaginitis Screening Kit Product Portfolio
6.7.5 BioMerieux Recent Developments/Updates
6.8 QuidelOrtho
6.8.1 QuidelOrtho Company Information
6.8.2 QuidelOrtho Description and Business Overview
6.8.3 QuidelOrtho Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 QuidelOrtho Vaginitis Screening Kit Product Portfolio
6.8.5 QuidelOrtho Recent Developments/Updates
6.9 Becton Dickinson
6.9.1 Becton Dickinson Company Information
6.9.2 Becton Dickinson Description and Business Overview
6.9.3 Becton Dickinson Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Becton Dickinson Vaginitis Screening Kit Product Portfolio
6.9.5 Becton Dickinson Recent Developments/Updates
6.10 Bio-Rad Laboratories
6.10.1 Bio-Rad Laboratories Company Information
6.10.2 Bio-Rad Laboratories Description and Business Overview
6.10.3 Bio-Rad Laboratories Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bio-Rad Laboratories Vaginitis Screening Kit Product Portfolio
6.10.5 Bio-Rad Laboratories Recent Developments/Updates
6.11 Hologic
6.11.1 Hologic Company Information
6.11.2 Hologic Description and Business Overview
6.11.3 Hologic Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hologic Vaginitis Screening Kit Product Portfolio
6.11.5 Hologic Recent Developments/Updates
6.12 Wuhan Easy Diagnosis
6.12.1 Wuhan Easy Diagnosis Company Information
6.12.2 Wuhan Easy Diagnosis Description and Business Overview
6.12.3 Wuhan Easy Diagnosis Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Wuhan Easy Diagnosis Vaginitis Screening Kit Product Portfolio
6.12.5 Wuhan Easy Diagnosis Recent Developments/Updates
6.13 Wondfo
6.13.1 Wondfo Company Information
6.13.2 Wondfo Description and Business Overview
6.13.3 Wondfo Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Wondfo Vaginitis Screening Kit Product Portfolio
6.13.5 Wondfo Recent Developments/Updates
6.14 KHB
6.14.1 KHB Company Information
6.14.2 KHB Description and Business Overview
6.14.3 KHB Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 KHB Vaginitis Screening Kit Product Portfolio
6.14.5 KHB Recent Developments/Updates
6.15 Hotgen
6.15.1 Hotgen Company Information
6.15.2 Hotgen Description and Business Overview
6.15.3 Hotgen Vaginitis Screening Kit Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Hotgen Vaginitis Screening Kit Product Portfolio
6.15.5 Hotgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaginitis Screening Kit Industry Chain Analysis
7.2 Vaginitis Screening Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaginitis Screening Kit Production Mode & Process Analysis
7.4 Vaginitis Screening Kit Sales and Marketing
7.4.1 Vaginitis Screening Kit Sales Channels
7.4.2 Vaginitis Screening Kit Distributors
7.5 Vaginitis Screening Kit Customer Analysis
8 Vaginitis Screening Kit Market Dynamics
8.1 Vaginitis Screening Kit Industry Trends
8.2 Vaginitis Screening Kit Market Drivers
8.3 Vaginitis Screening Kit Market Challenges
8.4 Vaginitis Screening Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Vaginitis Screening Kit Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Vaginitis Screening Kit Market Value by Disease Type (US$ Million), 2025 vs 2032
 Table 3. Global Vaginitis Screening Kit Market Value by Sample (US$ Million), 2025 vs 2032
 Table 4. Global Vaginitis Screening Kit Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Vaginitis Screening Kit Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Vaginitis Screening Kit Sales (M Units) of Key Manufacturers (2021–2026)
 Table 7. Global Vaginitis Screening Kit Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Vaginitis Screening Kit Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Vaginitis Screening Kit Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Vaginitis Screening Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Vaginitis Screening Kit, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Vaginitis Screening Kit, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Vaginitis Screening Kit, Product Types and Applications
 Table 14. Global Key Manufacturers of Vaginitis Screening Kit, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Vaginitis Screening Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vaginitis Screening Kit Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Vaginitis Screening Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Vaginitis Screening Kit Sales by Region (M Units), 2021–2026
 Table 20. Global Vaginitis Screening Kit Sales Market Share by Region (2021–2026)
 Table 21. Global Vaginitis Screening Kit Sales by Region (M Units), 2027–2032
 Table 22. Global Vaginitis Screening Kit Sales Market Share by Region (2027–2032)
 Table 23. Global Vaginitis Screening Kit Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Vaginitis Screening Kit Revenue Market Share by Region (2021–2026)
 Table 25. Global Vaginitis Screening Kit Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Vaginitis Screening Kit Revenue Market Share by Region (2027–2032)
 Table 27. North America Vaginitis Screening Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Vaginitis Screening Kit Sales by Country (M Units), 2021–2026
 Table 29. North America Vaginitis Screening Kit Sales by Country (M Units), 2027–2032
 Table 30. North America Vaginitis Screening Kit Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Vaginitis Screening Kit Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Vaginitis Screening Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Vaginitis Screening Kit Sales by Country (M Units), 2021–2026
 Table 34. Europe Vaginitis Screening Kit Sales by Country (M Units), 2027–2032
 Table 35. Europe Vaginitis Screening Kit Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Vaginitis Screening Kit Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Vaginitis Screening Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Vaginitis Screening Kit Sales by Region (M Units), 2021–2026
 Table 39. Asia Pacific Vaginitis Screening Kit Sales by Region (M Units), 2027–2032
 Table 40. Asia Pacific Vaginitis Screening Kit Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Vaginitis Screening Kit Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Vaginitis Screening Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Vaginitis Screening Kit Sales by Country (M Units), 2021–2026
 Table 44. Latin America Vaginitis Screening Kit Sales by Country (M Units), 2027–2032
 Table 45. Latin America Vaginitis Screening Kit Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Vaginitis Screening Kit Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Vaginitis Screening Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Vaginitis Screening Kit Sales by Country (M Units), 2021–2026
 Table 49. Middle East and Africa Vaginitis Screening Kit Sales by Country (M Units), 2027–2032
 Table 50. Middle East and Africa Vaginitis Screening Kit Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Vaginitis Screening Kit Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Vaginitis Screening Kit Sales (M Units) by Type (2021–2026)
 Table 53. Global Vaginitis Screening Kit Sales (M Units) by Type (2027–2032)
 Table 54. Global Vaginitis Screening Kit Sales Market Share by Type (2021–2026)
 Table 55. Global Vaginitis Screening Kit Sales Market Share by Type (2027–2032)
 Table 56. Global Vaginitis Screening Kit Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Vaginitis Screening Kit Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Vaginitis Screening Kit Revenue Market Share by Type (2021–2026)
 Table 59. Global Vaginitis Screening Kit Revenue Market Share by Type (2027–2032)
 Table 60. Global Vaginitis Screening Kit Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Vaginitis Screening Kit Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Vaginitis Screening Kit Sales (M Units) by Application (2021–2026)
 Table 63. Global Vaginitis Screening Kit Sales (M Units) by Application (2027–2032)
 Table 64. Global Vaginitis Screening Kit Sales Market Share by Application (2021–2026)
 Table 65. Global Vaginitis Screening Kit Sales Market Share by Application (2027–2032)
 Table 66. Global Vaginitis Screening Kit Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Vaginitis Screening Kit Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Vaginitis Screening Kit Revenue Market Share by Application (2021–2026)
 Table 69. Global Vaginitis Screening Kit Revenue Market Share by Application (2027–2032)
 Table 70. Global Vaginitis Screening Kit Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Vaginitis Screening Kit Price (US$/Unit) by Application (2027–2032)
 Table 72. Roche Company Information
 Table 73. Roche Description and Business Overview
 Table 74. Roche Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Roche Vaginitis Screening Kit Product
 Table 76. Roche Recent Developments/Updates
 Table 77. Abbott Company Information
 Table 78. Abbott Description and Business Overview
 Table 79. Abbott Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Abbott Vaginitis Screening Kit Product
 Table 81. Abbott Recent Developments/Updates
 Table 82. Danaher Company Information
 Table 83. Danaher Description and Business Overview
 Table 84. Danaher Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. Danaher Vaginitis Screening Kit Product
 Table 86. Danaher Recent Developments/Updates
 Table 87. Siemens Healthineers Company Information
 Table 88. Siemens Healthineers Description and Business Overview
 Table 89. Siemens Healthineers Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Siemens Healthineers Vaginitis Screening Kit Product
 Table 91. Siemens Healthineers Recent Developments/Updates
 Table 92. Thermo Fisher Scientific Company Information
 Table 93. Thermo Fisher Scientific Description and Business Overview
 Table 94. Thermo Fisher Scientific Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Thermo Fisher Scientific Vaginitis Screening Kit Product
 Table 96. Thermo Fisher Scientific Recent Developments/Updates
 Table 97. Sysmex Company Information
 Table 98. Sysmex Description and Business Overview
 Table 99. Sysmex Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Sysmex Vaginitis Screening Kit Product
 Table 101. Sysmex Recent Developments/Updates
 Table 102. BioMerieux Company Information
 Table 103. BioMerieux Description and Business Overview
 Table 104. BioMerieux Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. BioMerieux Vaginitis Screening Kit Product
 Table 106. BioMerieux Recent Developments/Updates
 Table 107. QuidelOrtho Company Information
 Table 108. QuidelOrtho Description and Business Overview
 Table 109. QuidelOrtho Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. QuidelOrtho Vaginitis Screening Kit Product
 Table 111. QuidelOrtho Recent Developments/Updates
 Table 112. Becton Dickinson Company Information
 Table 113. Becton Dickinson Description and Business Overview
 Table 114. Becton Dickinson Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. Becton Dickinson Vaginitis Screening Kit Product
 Table 116. Becton Dickinson Recent Developments/Updates
 Table 117. Bio-Rad Laboratories Company Information
 Table 118. Bio-Rad Laboratories Description and Business Overview
 Table 119. Bio-Rad Laboratories Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. Bio-Rad Laboratories Vaginitis Screening Kit Product
 Table 121. Bio-Rad Laboratories Recent Developments/Updates
 Table 122. Hologic Company Information
 Table 123. Hologic Description and Business Overview
 Table 124. Hologic Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. Hologic Vaginitis Screening Kit Product
 Table 126. Hologic Recent Developments/Updates
 Table 127. Wuhan Easy Diagnosis Company Information
 Table 128. Wuhan Easy Diagnosis Description and Business Overview
 Table 129. Wuhan Easy Diagnosis Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. Wuhan Easy Diagnosis Vaginitis Screening Kit Product
 Table 131. Wuhan Easy Diagnosis Recent Developments/Updates
 Table 132. Wondfo Company Information
 Table 133. Wondfo Description and Business Overview
 Table 134. Wondfo Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. Wondfo Vaginitis Screening Kit Product
 Table 136. Wondfo Recent Developments/Updates
 Table 137. KHB Company Information
 Table 138. KHB Description and Business Overview
 Table 139. KHB Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 140. KHB Vaginitis Screening Kit Product
 Table 141. KHB Recent Developments/Updates
 Table 142. Hotgen Company Information
 Table 143. Hotgen Description and Business Overview
 Table 144. Hotgen Vaginitis Screening Kit Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 145. Hotgen Vaginitis Screening Kit Product
 Table 146. Hotgen Recent Developments/Updates
 Table 147. Key Raw Materials Lists
 Table 148. Raw Materials Key Suppliers Lists
 Table 149. Vaginitis Screening Kit Distributors List
 Table 150. Vaginitis Screening Kit Customers List
 Table 151. Vaginitis Screening Kit Market Trends
 Table 152. Vaginitis Screening Kit Market Drivers
 Table 153. Vaginitis Screening Kit Market Challenges
 Table 154. Vaginitis Screening Kit Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaginitis Screening Kit
 Figure 2. Global Vaginitis Screening Kit Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Vaginitis Screening Kit Market Share by Type: 2025 & 2032
 Figure 4. Molecular PCR Assays Product Picture
 Figure 5. POC Antigen Tests Product Picture
 Figure 6. Lab Culture Kits Product Picture
 Figure 7. Multiplex Panels Product Picture
 Figure 8. Global Vaginitis Screening Kit Market Value by Disease Type (US$ Million), 2021–2032
 Figure 9. Global Vaginitis Screening Kit Market Share by Disease Type: 2025 vs 2032
 Figure 10. Bacterial Vaginosis Product Picture
 Figure 11. Yeast Infections Product Picture
 Figure 12. Trichomonas Product Picture
 Figure 13. Other Product Picture
 Figure 14. Global Vaginitis Screening Kit Market Value by Sample (US$ Million), 2021–2032
 Figure 15. Global Vaginitis Screening Kit Market Share by Sample: 2025 vs 2032
 Figure 16. Swab Product Picture
 Figure 17. Wet Product Picture
 Figure 18. Lysis Product Picture
 Figure 19. Other Product Picture
 Figure 20. Global Vaginitis Screening Kit Market Value by Application (US$ Million), 2021–2032
 Figure 21. Global Vaginitis Screening Kit Market Share by Application: 2025 & 2032
 Figure 22. Hospital
 Figure 23. Laboratory
 Figure 24. Others
 Figure 25. Global Vaginitis Screening Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 26. Global Vaginitis Screening Kit Market Size (US$ Million), 2021–2032
 Figure 27. Global Vaginitis Screening Kit Sales (M Units), 2021–2032
 Figure 28. Global Vaginitis Screening Kit Average Price (US$/Unit), 2021–2032
 Figure 29. Vaginitis Screening Kit Report Years Considered
 Figure 30. Vaginitis Screening Kit Sales Share by Manufacturers in 2025
 Figure 31. Global Vaginitis Screening Kit Revenue Share by Manufacturers in 2025
 Figure 32. Top 5 and Top 10 Global Vaginitis Screening Kit Players: Market Share by Revenue in Vaginitis Screening Kit in 2025
 Figure 33. Vaginitis Screening Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 34. Global Vaginitis Screening Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 35. North America Vaginitis Screening Kit Sales Market Share by Country (2021–2032)
 Figure 36. North America Vaginitis Screening Kit Revenue Market Share by Country (2021–2032)
 Figure 37. United States Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Canada Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Europe Vaginitis Screening Kit Sales Market Share by Country (2021–2032)
 Figure 40. Europe Vaginitis Screening Kit Revenue Market Share by Country (2021–2032)
 Figure 41. Germany Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. France Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. U.K. Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Italy Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Russia Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Asia Pacific Vaginitis Screening Kit Sales Market Share by Region (2021–2032)
 Figure 47. Asia Pacific Vaginitis Screening Kit Revenue Market Share by Region (2021–2032)
 Figure 48. China Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Japan Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. South Korea Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. India Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Australia Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. China Taiwan Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Southeast Asia Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Latin America Vaginitis Screening Kit Sales Market Share by Country (2021–2032)
 Figure 56. Latin America Vaginitis Screening Kit Revenue Market Share by Country (2021–2032)
 Figure 57. Mexico Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Brazil Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Argentina Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Colombia Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Middle East and Africa Vaginitis Screening Kit Sales Market Share by Country (2021–2032)
 Figure 62. Middle East and Africa Vaginitis Screening Kit Revenue Market Share by Country (2021–2032)
 Figure 63. Turkey Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 64. Saudi Arabia Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 65. UAE Vaginitis Screening Kit Revenue Growth Rate (US$ Million), 2021–2032
 Figure 66. Global Sales Market Share of Vaginitis Screening Kit by Type (2021–2032)
 Figure 67. Global Revenue Market Share of Vaginitis Screening Kit by Type (2021–2032)
 Figure 68. Global Vaginitis Screening Kit Price (US$/Unit) by Type (2021–2032)
 Figure 69. Global Sales Market Share of Vaginitis Screening Kit by Application (2021–2032)
 Figure 70. Global Revenue Market Share of Vaginitis Screening Kit by Application (2021–2032)
 Figure 71. Global Vaginitis Screening Kit Price (US$/Unit) by Application (2021–2032)
 Figure 72. Vaginitis Screening Kit Value Chain
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS